BREAKING: Melanoma Adjuvant Therapy Faces Reimbursement Concerns The lack of definitive overall survival data for adjuvant therapy in stage III melanoma is prompting worries about reimbursement and treatment… The post Melanoma Adjuvant Therapy: OS Data Gaps Explained appeared first on NewsyList. Source link
Summer Clothing Choices Linked to Skin Cancer Risk: What You Need to know Table of Contents Summer Clothing Choices Linked to Skin Cancer Risk: What You Need to know Summer Clothing Choices Linked to Skin Cancer Risk: What You Need to know Melanoma Hotspots: Gender Differences Did You Know? The Sun’s Impact: UV Radiation and … Read more
Melanoma Metastasis: Researchers Identify Key Biomarkers and Immune System Triggers Table of Contents Melanoma Metastasis: Researchers Identify Key Biomarkers and Immune System Triggers Biomarkers Indicate Metastatic Potential Embryonic Genes Activated in Cancer Cells Immune System Response Triggers “Rejuvenation” Potential Therapeutic targets Understanding Melanoma Metastasis: New Insights and Potential Treatments What is Melanoma Metastasis? what are … Read more
Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. The study, published in the journal Nano Letters, explores a way to make high-intensity focused ultrasound less harmful to healthy tissues. Oregon Health & Science University was the first hospital in Oregon to offer … Read more
TOPLINE: Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early recurrence during adjuvant targeted therapy. The blood-based biomarker outperforms traditional prognostic indicators including tumor mutational burden and interferon gamma gene expression. METHODOLOGY: Cell-free ctDNA is an established measure of … Read more
Chilean Biotech Firm Advances Cancer Vaccine Trials Table of Contents Chilean Biotech Firm Advances Cancer Vaccine Trials How the Vaccines Work Accessibility and Future Steps Chilean Biotech Firm Advances cancer Vaccine Trials: your Questions Answered What’s the headline news about cancer treatment? What are Tapcells and Lycellvax? Where are these vaccines being developed? How do … Read more
Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy. Results of their study were published in the Journal for Immunotherapy of Cancer. TIL therapy … Read more
A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled “GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells.” In this work, first author Diana Crisan and corresponding author Abhijit Basu from the University Hospital Ulm led a team that presents experimental evidence pointing to the protein … Read more
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method, based on whole-genome sequencing of DNA, also represents … Read more
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors. The study, published in The Journal of ImmunoTherapy of Cancer, details how an immunoprotected device near the tumor microenvironment containing cells … Read more